Antibody Target, Technology & Pipeline Database: 1-Year Subscription
Subscription to La Merie Publishing’s proprietary Antibody Database provides online access to information about more than 2,400 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their
To Read The Complete Report with TOC:-
· Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)
· Target (e.g. Her2, CD20, TNF, PD-1/PD-L1)
· Pipelines (selected by target, therapeutic area, company, technology)
· Sales (for marketed antibodies)
· R&D Phase (clinical phases, market, preclinical)
· Territory (countrywise)
· Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
· Drug Code/Name (for individual molecules)
Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antidoies on the market are provided.
To Buy a Copy Of This Report:-
An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.
Special Focus of the Database:
· Antibody-Drug Conjugates
· Bispecific Antibodies
· Biosimilar and Biosuperior Antibodies
Contact:-
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment